Delek US Holdings Inc

Stage 2 advancing with sustained higher highs and higher lows above rising EMAs provides a bullish medium-term bias, but extreme overbought conditions and a steep Parabola acceleration heighten reversal risk; execution is deferred until a shallow pullback into rising EMA support.

• ↑Earnings yield of 2.49% with strong revisions indicates undervaluation.
• ↑Q1 adjusted EBITDA $212M; Q2 throughput guided at 293–313K bbl/d.
• ↓Q1 net loss of $201M (−$3.34/share) driven by turnaround charges.